Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF UROLOGY
Volume 29, Issue 1, Pages 59-71
Publisher
Springer Nature
Online
2010-11-27
DOI
10.1007/s00345-010-0617-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer
- (2010) Vincenzo Serretta et al. BJU INTERNATIONAL
- Clinical Outcomes of Primary Bladder Carcinoma In Situ in a Contemporary Series
- (2010) Daher C. Chade et al. JOURNAL OF UROLOGY
- Clinical Outcome of Primary Versus Secondary Bladder Carcinoma In Situ
- (2010) Daher C. Chade et al. JOURNAL OF UROLOGY
- Bacillus Calmette-Guérin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study
- (2010) Massimo Porena et al. UROLOGIA INTERNATIONALIS
- Late Recurrence and Progression in Non-muscle–invasive Bladder Cancers After 5-year Tumor-free Periods
- (2010) Kazuhiro Matsumoto et al. UROLOGY
- Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study
- (2010) Takashi Saika et al. WORLD JOURNAL OF UROLOGY
- Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up
- (2009) Riikka Järvinen et al. EUROPEAN UROLOGY
- Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
- (2009) Sigurdur Gudjónsson et al. EUROPEAN UROLOGY
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
- (2009) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study
- (2009) Miloš Duchek et al. EUROPEAN UROLOGY
- Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association
- (2009) Eiji Kikuchi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer
- (2009) B. K. Hollenbeck et al. JNCI-Journal of the National Cancer Institute
- Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-invasive Bladder Cancer Refractory to Standard Intravesical Therapy
- (2009) Melissa A. Laudano et al. UROLOGY
- Updates in intravesical electromotive drug administration® of mitomycin-C for non-muscle invasive bladder cancer
- (2009) Savino Mauro Di Stasi et al. WORLD JOURNAL OF UROLOGY
- Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer
- (2008) Marc Decobert et al. CANCER
- EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
- (2008) Marko Babjuk et al. EUROPEAN UROLOGY
- Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: The impact of previous intravesical treatment
- (2008) Takehiko Okamura et al. INTERNATIONAL JOURNAL OF UROLOGY
- An Analysis of the Effect of Statin Use on the Efficacy of Bacillus Calmette-Guerin Treatment for Transitional Cell Carcinoma of the Bladder
- (2008) Ryan K. Berglund et al. JOURNAL OF UROLOGY
- The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapy
- (2008) Ofer N. Gofrit et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer
- (2008) Seth P. Lerner et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Low-Dose Instillation Therapy with Bacille Calmette-Guérin Tokyo 172 Strain After Transurethral Resection: Historical Cohort Study
- (2008) Takahiro Yoneyama et al. UROLOGY
- Comparison of Three Schedules of Intravesical Epirubicin in Patients with Non–Muscle-Invasive Bladder Cancer
- (2007) Kees Hendricksen et al. EUROPEAN UROLOGY
- Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
- (2007) Jesus Fernandez-Gomez et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started